Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-06
1999-08-03
Wortman, Donna
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242831, 424812, 530327, 530328, 530329, A61K 3929, A61K 4744, A61K 3808, A61K 3810
Patent
active
059322241
ABSTRACT:
Peptides are used to define epitopes that stimulate HLA-restricted cytotoxic T lymphocyte activity against hepatitis B virus antigens. The peptides are derived from regions of HBV polymerase, and are particularly useful in treating or preventing HBV infection, including methods for stimulating the immune response of chronically infected individuals to respond to HBV antigens.
REFERENCES:
patent: 4235877 (1980-11-01), Fullerton
patent: 4428941 (1984-01-01), Galibert et al.
patent: 4487715 (1984-12-01), Nitecki et al.
patent: 4599230 (1986-07-01), Milich et al.
patent: 4599231 (1986-07-01), Milich et al.
patent: 4818527 (1989-04-01), Thornton et al.
patent: 4882145 (1989-11-01), Thornton et al.
patent: 4935235 (1990-06-01), Rutter et al.
patent: 5017558 (1991-05-01), Vyas
patent: 5019386 (1991-05-01), Machida et al.
patent: 5039522 (1991-08-01), Neurath
patent: 5100662 (1992-03-01), Bolcsak et al.
Zinkernagel et al., "The Lymphoreticular System in Triggering Virus Plus Self-Specific Cytotoxic T Cells: Evidence for T Help", J. Exp. Med., 147:897-911 (1978).
Galibert et al., "Nucleotide Sequence of the Hepatitis B Virus Genome (subtype ayw) Cloned in E. Coli", Nature 281:646-650 (Oct. 25, 1979).
von Boehmer et al., "Distinct Ir Genes for Helper and Killer Cells in the Cytotoxic Response to H-Y Antigen", J. Exp. Med., 150:1134-1142 (Nov., 1979).
Melief et al., "Cooperation Between Subclasses of T Lymphocytes in the in vitro Generation of Cytotoxicity Against a Mutant H-2K Difference An Analysis with Anti-Lyt Antisera", Eur. J. Immunol. 9:7-12 (1979).
Widmer et al., "Antigen-Driven Helper Cell-independent Cloned Cytolytic T Lymphocytes", Nature 294:750-752 (1981).
Lerner et al., "Chemically Synthesized Peptides Predicted form the Nucleotide Sequence of the Hepatitis B Virus Genome Elicit Antibodies Reactive with the Native Envelope Protein of Dane Particles" Proc. Natl. Acad. Sci. USA 78:3403-3407 (Jun. 1981).
Bhatnagar et al., "Immune Response to Synthetic Peptide Analogues of Hepatitis B Surface Antigen Specific for the Determinant" Proc. Natl. Acad. Sci. USA 79:4400-44-4 (Jul. 1982).
Mondelli et al., "Specificity of T Lymphocyte Cytotoxicity to Autologous Hepatocytes in Chronic Hepatitis B Virus Infection: Evidence that T Cells are Directed Against HBV Core Antigen Expressed on Hepatocytes", J. Immunol., 129:2773-2778 (Dec. 1982).
von Boehmer et al., "Autonomously Proliferating K/D-restricted Cytolytic T Cell Clones", Eur. J. Immunol. 13:176-179 (1983).
Neurath et al., "Specificity of Antibodies Elicited by a Synthetic Peptide having a Sequence in Common with a Fragment of a Virus Protein--The Hepatitis B Surface Antigen", Develop. Biol. Standard, 54:103-112 (1983).
von Boehmer et al., "Lyt-2 T Cell-Independent Functions of Lyt-2+ Cells Stimulated with Antigen or Concanavalin A", J. Immunol., 133:59-64 (Jul., 1984).
Hopp, "Immunogenicity of a synthetic HBsAg Peptide: Enhancement by Conjugate to a Fatty Acid Carrier", Molecular Immunol. 21:13-16 (1984).
Milich et al., "Immunogenetics and Cellular Correlates of the Immune Response to Hepatitis B Surface Antigen Determinants", Adv. Hepatitis Res. Masson, NY, NY USA 91-109 (1984).
Fujii et al., "Peptide Chemistry 1983" published 1984 by Protein Research Foundation (Osaka), pp. 215-220.
Bichko et al., "Subtype ayw Variant of Hepatits B Virus", FEBS Lett. 185:208-212 (Jun., 1985).
Sprent et al., "Properties of Purified T Cell Subsets", J. Exp. Med., 162:2068-2088 (Dec., 1985).
Townsend et al., "The Epitopes of Influenza Nucleoprotein Recognized by Cytotoxic T Lymphocytes Can Be Defined with Short Synthetic Peptides", Cell 44:959-968 (Mar. 28, 1986).
Bessler et al., "The Synthetic Analog of Bacterial Lipoprotein are Potent Immunoadjuvants in Combination with or Covalently Linked to Antigen", Prog. Leukocyte Biol. 5:337-344 (1986).
Watari et al., "A Synthetic Peptide Induces Long-Term Protection from Lethal Infection with Herpes Simplex Virus 2", J. Exp. Med., 165:459-470 (Feb., 1987).
Gotch et al., "Cytotoxic T Lymphocytes Recognize a Fragment of Influenza Virus Matrix Protein in Associate with HLA-A2", Nature 326:881-882 (Apr. 30, 1987).
Buller et al. "Induction of Cytotoxic T-Cell Responses in vivo in Absence of CD4 Helper Cells" Nature 328:76-79 (Jul. 2, 1987).
Milich et al., "Immune Response to Hepatitis B Virus Core Antigen (HBcAg): Localization of T Cell Recognition Sites Within HBcAg/HBeAg", J. Immunol., 139:1223-1231 (Aug. 15, 1987).
Milich et al., "Antibody Production to the Nucleocapsid and Envelope of the Hepatitis B Virus Primed by a Single Synthetic T Cell Site", Nature 329:547-549 (Oct. 8, 1987).
Mondelli et al. "Definition of Hepatitis B Virus (HBV)--specific Target Antigens Recognized by Cytotoxic T Cells in Acute HBV Infection", Clin. Exp. Immunol., 68:242-250 (1987).
Milich et al., "Hepatitis B Synthetic Immunogen Comprised of Nucleocapsid T-cell Sites and an Envelope B-cell Epitope", Proc. Natl. Acad. Sci. USA 85:1610-1614 (Mar., 1988).
Celis et al., "Recognition of Hepatitis B Surface Antigen by Human T Lymphocytes" J. Immunol. 140:1808-1815 (Mar. 15, 1988).
Carbone et al. "Induction of Cytotoxic T Lymphocytes by Primary in vitro Stimulation with Peptides", J. Exp. Med., 167:1767-1779 (Jun., 1988).
Moore et al., "Introduction of Soluble Protein into the Class I Pathway of Antigen Processing and Presentation", Cell 54:777-785 (Sep. 9, 1988).
Milich et al., "Comparative Immunogenicity of Hepatitis B Virus Core and E Antigens", J. Immunol. 141:3617-3624 (Nov. 15, 1988).
Gotch et al. "Recognition of Influenza A Matrix Protein by HLA-A2-Restricted Cytotoxic T Lymphocytes", J. Exp. Med. 163:2045-2057 (Dec., 1988).
Mack et al., "Hepatitis B Virus Particles Contain a Polypeptide Encoded by the Largest Open Reading Frame: A Putative Reverse Transcriptase", J. Virol. 62:4786-4790 (Dec., 1988).
Milich, "T- and B-cell Recognition of Hepatitis B Viral Antigens", Immunol. Today 9:380-386 (1988).
Hayashi et al., "Studies on Peptides CLXVI. Solid-Phase Synthesis and Immunological Properties of Fragment Peptides Related to Human Hepatitis B virus Surface Antigen (HBsAg) and Its Pre-S2 Gene" Chem. Pharm. Bull. 36(12):4993-4994 (1988).
Braciale et al., "Class I Major Histocompatibility Complex-restricted Cytolytic T Lymphocytes Recognize a Limited Number of sites on the Influenza Hemagglutinin", Proc. Natl. Acad. Sci. USA 86:277-281 (Jan., 1989).
Ishioka et al., "Induction of Class I MHC-restricted, Peptide-specific Cytolytic T Lymphocytes by Peptide Priming in vivo", J. Immunol., 143:1094-1100 (Aug. 15, 1989).
Klavinskis et al., "Molecularly Engineered Vaccine Which Expresses an Immunodominant T-cell Epitope Induces Cytotoxic T Lymphocytes that Confer Protection for Lethal Virus Infection," J. Virol., 63:4311-4316 (Oct., 1989).
Bevan, "Stimulating Killer Cells", Nature 342:478-479 (Nov. 30, 1989).
Deres et al., "In Vivo Priming of Virus-Specific Cytotoxic T Lymphocytes with Synthetic Lipopeptide Vaccine", Nature 342:561-564 (Nov. 30, 1989).
Tam et al., "Vaccine Engineering: Enhancement of Immunogenicity of Synthetic Peptide Vaccines Related to Hepatitis in Chemically Defined Models Consisting of T- and B-cell Epitopes", Proc. Natl. Acad. Sci. USA 86:9084-9088 (Dec. 1989).
Chisari et al., "Hepatitis B Virus Structure and Biology", Microbial Pathogenesis 6:311-325 (1989).
Carbone et al., "Induction of Ovalubumin-Specific Cytotoxic T Cells by in vivo Peptide Immunization", J. Exp. Med., 169:603-612 (1989).
Moriyama et al., "Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic Mice", Science 248:361-364 (Apr. 20, 1990).
Aichele et al., "Antiviral Cytotoxic T Cell Response Induced by in vivo Priming with a Free Synthetic Peptide", J. Exp. Med., 171:1815-1820 (May, 1990).
Aggarwal et al., "Oral Salmonella: Malaria Circumsporozoite Recombinants Induce Specific CD8.sup.+ Cytotoxic T Cells", J. Exp. Med., 172:1083-1090 (Oct., 1990).
Van Bleek et al., "Isolation of an Endogenously Processed Immunodominant Viral Peptide from the Class IH-2K.sup.b Molecule", Nature 348:213-216 (Nov. 15, 1990).
Rotzschke et al.
The Scripps Research Institute
Wortman Donna
LandOfFree
Peptides for inducing cytotoxic T lymphocyte responses to hepati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for inducing cytotoxic T lymphocyte responses to hepati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for inducing cytotoxic T lymphocyte responses to hepati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-847485